Feasibility of nephrinuria as a screening tool for the risk of pre-eclampsia: prospective observational study
Tóm tắt
To investigate the possibility of nephrinuria as a screening tool for the risk of pre-eclampsia (PE).
Prospective observational study.
A single university hospital. Changes in urinary nephrin:creatinine ratio (NCR, ng/mg) and protein:creatinine ratio (PCR, mg/mg) in pregnancy were determined. Significant proteinuria in pregnancy (SPIP) was defined as PCR>0.27. PE was diagnosed in women with both SPIP and hypertension.
89 pregnant women in whom neither hypertension nor SPIP was present at enrolment, providing 31, 125 and 93 random urine samples during first, second and third trimesters, respectively.
PE developed in 14 of the 89 women. NCR increased with increasing PCR in 14 women with PE (correlation coefficient, 0.862; p<0.0001). In contrast, NCR did not change significantly despite significant increases in PCR in 75 women with normotensive pregnancies defined as neither SPIP nor hypertension, indicating that there was little increase in nephrinuria over the physiological range of proteinuria in pregnancy. Relative risk of later development of PE among asymptomatic second and third trimester women with NCR (ng/mg) >122 (95th centile value for 75 women with normotensive pregnancies) was 5.93 (95% CI 2.59 to 13.6; 60% (6/10) vs 10% (8/79)) and 13.5 (95% CI 3.31 to 55.0; 75% (6/8) vs 5.5% (2/36)), respectively, compared with women with NCR≤122 at that time.
Nephrinuria was unlikely to increase in normal pregnancy. A certain NCR cut-off may efficiently differentiate women at higher risk of PE.
Từ khóa
Tài liệu tham khảo
Konieczny, 2013, Podocytes in urine, a novel biomarker of preeclampsia?, Adv Clin Exp Med, 22, 145
Smith, 2010, Protein:creatinine ratio in uncomplicated twin pregnancy, Am J Obstet Gynecol, 203, 381.e1, 10.1016/j.ajog.2010.06.013
NICE Clinical Guideline 107. Hypertension in Pregnancy; The Management of Hypertensive Disorders During Pregnancy. Issued 2010, last modified: January 2011. https://www.nice.org.uk/guidance/cg107/resources/guidance-hypertension-in-pregnancy-pdf (accessed 26 Sep 2015).
Magee, 2014, Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary, J Obstet Gynaecol Can, 36, 575, 10.1016/S1701-2163(15)30533-8
Morikawa, 2013, Effect of nulliparity, maternal age, and pre-pregnancy body mass index on the development of gestational hypertension and preeclampsia, Hypertensin Res Pregnancy, 1, 75, 10.14390/jsshp.1.75